drugset / Trial / NCT02361736

Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery

NCT02361736

RandomizedParallel-groupTriple-blind

Summary

Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old patients with normal renal function during orthopaedic surgery.

Timeline

Start
2015-03
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactate Ringers Unknown 7.5 unknown Intravenous
Subject hydroxyethyl starch Other / unclassified 7.5 unknown Intravenous

Indications

No indication recorded.